Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

The ‘Stay European’ Movement 

There is a campaign that is urging Brits to declare themselves…
Read more

IAEA finds uranium particles at Iranian sites

The International Atomic Energy Agency (IAEA) recently found…
Read more

Left Targeting K-12 

The left keeps going further and further into infiltrating…
Read more